Given the complexity of TGFβ signaling in aneurysm pathogenesis6, 32, and aortic heterogeneity in embryonic origin and local hemodynamic stress40, 41, caution should be taken when considering SMAD3 or TGF-β signaling pathways as the pharmacological target. This evidence concerns the gene SMAD3 and aneurysm.